103 related articles for article (PubMed ID: 7706174)
21. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae.
Pikis A; Donkersloot JA; Akram S; Keith JM; Campos JM; Rodriguez WJ
J Antimicrob Chemother; 1997 Jul; 40(1):105-8. PubMed ID: 9249211
[TBL] [Abstract][Full Text] [Related]
22. [Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty].
Yenişehirli G; Sener B
Mikrobiyol Bul; 2003 Jan; 37(1):1-11. PubMed ID: 12838672
[TBL] [Abstract][Full Text] [Related]
23. [Antibiotic resistance in pneumococci].
Moreillon P; Wenger A
Schweiz Med Wochenschr; 1996 Feb; 126(7):255-63. PubMed ID: 8720323
[TBL] [Abstract][Full Text] [Related]
24. Penicillin-resistant and -intermediate Streptococcus pneumoniae in Saudi Arabia.
Shibl AM; Al Rasheed AM; Elbashier AM; Osoba AO
J Chemother; 2000 Apr; 12(2):134-7. PubMed ID: 10789552
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis.
Tweardy DJ; Jacobs MR; Speck WT
J Antimicrob Chemother; 1983 Aug; 12(2):133-9. PubMed ID: 6555189
[TBL] [Abstract][Full Text] [Related]
26. [Pneumococci resistant to penicillin].
Moraga Llop FA; Sarto J; del Valle O; Belmonte JA; Iglesias J; Gallart A
An Esp Pediatr; 1987 Apr; 26(4):267-70. PubMed ID: 3605877
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effect of cefepime with four cephalosporins against pneumococci with various susceptibilities to penicillin, in vitro and in the mouse peritonitis model.
Knudsen JD; Fuursted K; Frimodt-Møller N; Espersen F
J Antimicrob Chemother; 1997 Nov; 40(5):679-86. PubMed ID: 9421316
[TBL] [Abstract][Full Text] [Related]
28. Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.
Zhanel GG; Yachison C; Nichol K; Adam H; Noreddin AM; Hoban DJ; Karlowsky JA
J Antimicrob Chemother; 2012 Jul; 67(7):1706-11. PubMed ID: 22467630
[TBL] [Abstract][Full Text] [Related]
29. [Sensitivity of Streptococcus pneumoniae to antimicrobial drugs].
Mihajlović-Ukropina M; Milutinović M
Med Pregl; 1998; 51(3-4):169-73. PubMed ID: 9611963
[TBL] [Abstract][Full Text] [Related]
30. [Antibiotic resistance analysis of
Ge LL; Han ZY; Liu AH; Zhu L; Meng JH
Zhonghua Er Ke Za Zhi; 2017 Feb; 55(2):109-114. PubMed ID: 28173648
[No Abstract] [Full Text] [Related]
31. Susceptibility of Streptococcus pneumoniae strains isolated in Italy to penicillin and ten other antibiotics.
Marchese A; Debbia EA; Arvigo A; Pesce A; Schito GC
J Antimicrob Chemother; 1995 Nov; 36(5):833-7. PubMed ID: 8626265
[TBL] [Abstract][Full Text] [Related]
32. A comparative study of the in-vitro activity of cefepime and other antimicrobial agents against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Yee YC; Thornsberry C; Brown SD; Bouchillon SK; Marler JK; Rich T
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():13-9. PubMed ID: 8150756
[TBL] [Abstract][Full Text] [Related]
33. [Antibiotics-resistance pattern and genetic type of Streptococcus pneumoniae isolated from children in Hangzhou].
Hua CZ; Shang SQ; Sun XF; Li JP; Chen ZM; Yu XL
Zhonghua Er Ke Za Zhi; 2004 Jan; 42(1):16-9. PubMed ID: 14990098
[TBL] [Abstract][Full Text] [Related]
34. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae.
Kim BN; Woo JH; Kim YS; Ryu J; Kim MN; Pai CH
Chemotherapy; 2000; 46(5):303-8. PubMed ID: 10965094
[TBL] [Abstract][Full Text] [Related]
35. Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae.
Haas DW; Stratton CW; Griffin JP; Weeks L; Alls SC
Clin Infect Dis; 1995 Mar; 20(3):671-6. PubMed ID: 7756494
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial activities of beta-lactam antibiotics and gentamicin against penicillin-susceptible and penicillin-resistant pneumococci.
Gross ME; Giron KP; Septimus JD; Mason EO; Musher DM
Antimicrob Agents Chemother; 1995 May; 39(5):1166-8. PubMed ID: 7625807
[TBL] [Abstract][Full Text] [Related]
37. Nasopharyngeal carriage of community-acquired, antibiotic-resistant Streptococcus pneumoniae in a Zambian paediatric population.
Woolfson A; Huebner R; Wasas A; Chola S; Godfrey-Faussett P; Klugman K
Bull World Health Organ; 1997; 75(5):453-62. PubMed ID: 9447779
[TBL] [Abstract][Full Text] [Related]
38. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
Knudsen JD
Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
[TBL] [Abstract][Full Text] [Related]
39. Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci.
Viladrich PF; Gudiol F; Liñares J; Rufi G; Ariza J; Pallares R
Am J Med; 1988 May; 84(5):839-46. PubMed ID: 3364443
[TBL] [Abstract][Full Text] [Related]
40. [Bacteriostatic activity and killing curves of eight antibiotics against seven strains of penicillin G-resistant pneumococci].
Barakett V; Lesage D; Delisle F; Guidet B; Burghoffer B; Richard G; Offenstadt G; Vergez P; Petit JC
Pathol Biol (Paris); 1992 May; 40(5):483-91. PubMed ID: 1495831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
